Harpoon Therapeutics, Inc. Common Stock
HARP
HARP was delisted on the 8th of March, 2024.
53 hedge funds and large institutions have $223M invested in Harpoon Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 9 closing their positions.
144% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 9
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
33% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 9
6% more funds holding
Funds holding: 50 → 53 (+3)
20% less capital invested
Capital invested by funds: $279M → $223M (-$55.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
+$4.92M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$4.89M |
| 3 |
BlackRock
New York
|
+$4.87M |
| 4 |
DM
Deerfield Management
New York
|
+$2.36M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$2.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$13.4M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$5.68M |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$503K |
| 4 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$444K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$297K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MAM
51
Meeder Asset Management
Dublin,
Ohio
| $1K | +$1.83K | +13 | New |
|
|
EC
52
EcoR1 Capital
San Francisco,
California
| – | -$13.4M | -90,855 | Closed |
|
|
SFM
53
Sphera Funds Management
Tel Aviv,
Israel
| – | -$5.68M | -38,403 | Closed |
|
|
BFM
54
Boothbay Fund Management
New York
| – | -$503K | -3,400 | Closed |
|
|
55
CIBC World Market
Toronto,
Ontario, Canada
| – | -$444K | -3,000 | Closed |
|
|
OAM
56
Oxford Asset Management
Oxford,
United Kingdom
| – | -$297K | -2,007 | Closed |
|
57
Goldman Sachs
New York
| – | -$164K | -1,106 | Closed |
|
|
TRCT
58
Tower Research Capital (TRC)
New York
| – | -$26K | -177 | Closed |
|
59
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$14K | -92 | Closed |
|
60
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$7.59K | -54 | -96% |
|
|
CWA
61
Capital Wealth Alliance
Scottsdale,
Arizona
| – | -$5K | -40 | Closed |
|
62
First Manhattan
New York
| – | +$984 | +7 | New |
|
HARP Hedge Fund Activity: Q1 2020 in Review
53 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Harpoon Therapeutics, Inc. Common Stock (HARP) for Q1 2020, worth a combined $223M — down 20% from $279M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new HARP positions and 9 closed out — a net gain of 3 holders — while 22 added to existing stakes and 9 trimmed.
The largest buyer was Artal Group, adding an estimated $4.92M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $13.4M sold.
- 53 institutional investors held Harpoon Therapeutics, Inc. Common Stock (HARP) as of Q1 2020, up from 50 in Q4 2019.
- Funds reported $223M of Harpoon Therapeutics, Inc. Common Stock stock for Q1 2020, down 20% quarter-over-quarter.
- 12 funds opened new Harpoon Therapeutics, Inc. Common Stock positions in Q1 2020 and 9 closed out, a net change of +3 holders.
- The largest Harpoon Therapeutics, Inc. Common Stock buyer in Q1 2020 was Artal Group, an estimated $4.92M added.
- The largest Harpoon Therapeutics, Inc. Common Stock seller in Q1 2020 was EcoR1 Capital, an estimated $13.4M sold.
Based on aggregated 13F filings for Q1 2020.